FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutical industry, in particular to medication, increasing non-specific resistance of organism to bacterial endotoxins. Medication, increasing non-specific resistance of organism to bacterial endotoxins, characterised by the fact that it represents mixture of k- and λ-carageenans, obtained from laver Chondrus armatus by means of water extraction and further sedimentation with ethanol, consisting of definite amount of galactose and 6-anhydrogalactose, containing sulphates and protein.
EFFECT: claimed medication efficiently increases non-specific resistance of organism to bacterial endotoxins.
1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FERMENTED MILK BEVERAGE | 2008 |
|
RU2375878C1 |
| AGENT FOR REDUCING SYSTEMIC PATHOLOGIC ENDOTOXINEMIA | 2014 |
|
RU2564918C1 |
| METHOD OF PROCESSING RED ALGAE | 2010 |
|
RU2428999C1 |
| METHOD FOR DIAGNOSTICS OF LATENT DISEASES BASING ON SYSTEMIC ENDOTOXAMIA INDICES | 2015 |
|
RU2609763C1 |
| CURD ICE CREAM | 2008 |
|
RU2409969C2 |
| ANTIVIRAL AGENT AGAINST HERPES SIMPLEX VIRUS TYPE 1 | 2022 |
|
RU2782935C1 |
| CARAGEENAN-CONTAINING AQUEOUS ANTIMICROBIAL COMPOSITIONS | 2010 |
|
RU2540423C2 |
| METHOD FOR MODELING PYELONEPHRITIS | 1999 |
|
RU2149463C1 |
| METHOD FOR EVALUATING ENDOTOXINEMIA IN CHILDREN SUFFERING FROM ATOPIC BRONCHIAL ASTHMA | 2000 |
|
RU2177616C1 |
| METHOD FOR ISOLATION OF BIOACTIVE FRACTION (BAF) CONTAINING S-LIPOPOLYSACCHARIDES (S-LPS) FROM GRAM-NEGATIVE BACTERIA, BAF FOR PREVENTION AND TREATMENT OF DISEASES INDUCED BY ENDOTOXIC S-LPS PRODUCING GRAM-NEGATIVE BACTERIA, PHARMACEUTICAL COMPOSITION, METHODS FOR INDUCING OF PROTECTIVE IMMUNITY AND IMPROVING STATE IN PATIENT IN NEED OF IMMUNE STATUS INCREASING | 2002 |
|
RU2260053C2 |
